American Century Companies’s Cullinan Oncology CGEM Stock Holding History

American Century Companies's CGEM Position: Q1 2026 in Review

American Century Companies increased its Cullinan Oncology (CGEM) stake by 0.94% in Q1 2026, buying an estimated $17.3K and bringing the position to 144,107 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

American Century Companies first reported a position in CGEM in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.34M in Q2 2023. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

• American Century Companies held 144,107 shares of Cullinan Oncology worth $2.05M as of Q1 2026.
• American Century Companies bought 1,346 Cullinan Oncology shares in Q1 2026, an estimated $17.3K.
• Cullinan Oncology made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2109 holding.
• American Century Companies first reported a position in Cullinan Oncology in Q3 2022 and has held it in 15 quarters since.
• American Century Companies's Cullinan Oncology position peaked at $3.34M in Q2 2023.
• 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.